analyst
KU
NASDAQ · KURA
Kura Oncology, Inc.
Healthcare · Biotechnology
$13.25
Up+$0.10 (+0.76%)
Updated Sep 7, 2026, 6:06 AM
SID Score
6.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 911.06M
- P/E ratio
- -4.23
- Dividend yield
- 0.00%
- 52-week range
- $7.54 – $13.90
- Volume
- 1.31M
- Avg. volume
- 1.89M
Price performance
KURA price history
1M range · 20 trading sessions · Daily adjusted prices
KURA closed at $13.25 after 20 trading sessions, up 34.52% for the selected period.
- Last close
- $13.25
- Period change
- +34.52%
- Period low
- $9.85
- Period high
- $13.59
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 4, 2026 | $12.94 | $13.27 | $12.89 | $13.25 | 1.31M |
| Sep 3, 2026 | $13.25 | $13.29 | $12.8505 | $13.15 | 1.48M |
| Sep 2, 2026 | $12.89 | $13.41 | $12.665 | $13.11 | 1.88M |
| Sep 1, 2026 | $12.54 | $12.96 | $12.432 | $12.89 | 1.51M |
| Aug 31, 2026 | $12.71 | $12.76 | $12.525 | $12.65 | 1.96M |
| Aug 28, 2026 | $13.05 | $13.17 | $12.61 | $12.66 | 1.81M |
| Aug 27, 2026 | $12.98 | $13.36 | $12.89 | $13.18 | 2.37M |
| Aug 26, 2026 | $13.63 | $13.66 | $12.9853 | $13.06 | 2.71M |
| Aug 25, 2026 | $13.59 | $13.90 | $12.85 | $13.59 | 5.38M |
| Aug 24, 2026 | $11.77 | $12.87 | $11.43 | $12.40 | 2.7M |
| Aug 21, 2026 | $11.78 | $12.248 | $11.67 | $11.89 | 2.03M |
| Aug 20, 2026 | $12.36 | $12.50 | $11.65 | $11.71 | 2.13M |
| Aug 19, 2026 | $12.74 | $12.90 | $12.43 | $12.53 | 4.08M |
| Aug 18, 2026 | $11.985 | $12.845 | $11.985 | $12.33 | 4.09M |
| Aug 17, 2026 | $10.945 | $11.34 | $10.76 | $11.28 | 2.1M |
| Aug 14, 2026 | $9.985 | $11.02 | $9.92 | $10.86 | 1.89M |
| Aug 13, 2026 | $10.605 | $11.31 | $9.99 | $10.09 | 4.48M |
| Aug 12, 2026 | $10.00 | $10.06 | $9.77 | $9.94 | 1.15M |
| Aug 11, 2026 | $9.88 | $9.99 | $9.70 | $9.93 | 876.71K |
| Aug 10, 2026 | $9.49 | $9.92 | $9.46 | $9.85 | 1.7M |
Latest KURA news
The latest Smart Investors Daily articles mentioning KURA.
Stock researchCompany · Overview
Loading stock research…

